(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MPX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MPX

ST13

US500000079384520

Class

1, 5, 42, 44

Filing

79384520

Registration

7656511

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

04/03/2026

Trademark type

Word

Nice classes

1, 5, 42, 44

Filing date

10/23/2023

Registration date

01/21/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/21/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

SE

Examiner

PARKS, KIMBERLY L

Law office

M30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Pixelgen Technologies AB

Representatives

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.

Technical classification

Nice Classes

Class 1Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic reagents for scientific or research use; reagents for scientific or medical research use; biomolecule labelling kits comprising biochemical reagents for scientific purposes; chemical reagents for molecular biologyother than for medical or veterinary use; biochemical diagnostic reagentsother than for medical use for sale in kit form; reagents for use in analytical tests for testing cells and tissuesother than for medical or veterinary purposes; the preceding goods not in relation to dosing apparatus or dosing systems

Class 5

Clinical medical diagnostic reagents; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; the preceding goods not in relation to dosing apparatus or dosing systems

Class 42

Laboratory servicesscientific laboratory services

Class 44

Medical diagnostic services

Publications

History of USPTO decisions and trademark events.

25 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/22/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/05/2025

FIMP

FINAL DISPOSITION PROCESSED

08/05/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/24/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/06/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/06/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/21/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/21/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/21/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2024

PUBO

PUBLISHED FOR OPPOSITION

12/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/27/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/04/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/29/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/29/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/29/2024

RFNT

REFUSAL PROCESSED BY IB

07/20/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/30/2024

RFRR

REFUSAL PROCESSED BY MPU

06/30/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/15/2024

CNRT

NON-FINAL ACTION WRITTEN

06/07/2024

DOCK

ASSIGNED TO EXAMINER

06/05/2024

MAFR

APPLICATION FILING RECEIPT MAILED

12/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/08/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/07/2023

Continuous trademark protection

Get notified about every new filing that threatens MPX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.